HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julia D Wulfkuhle Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

7/2011Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julia D Wulfkuhle Research Topics

Disease

28Neoplasms (Cancer)
11/2021 - 11/2002
14Breast Neoplasms (Breast Cancer)
12/2021 - 11/2002
4Neoplasm Metastasis (Metastasis)
07/2011 - 04/2008
3Pathologic Complete Response
12/2021 - 01/2018
3Carcinogenesis
11/2012 - 04/2003
2Prostatic Neoplasms (Prostate Cancer)
09/2011 - 06/2009
1Triple Negative Breast Neoplasms
12/2021
1Hyperglycemia
10/2021
1Lung Neoplasms (Lung Cancer)
10/2021
1Squamous Cell Carcinoma of Head and Neck
01/2020
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
06/2017
1Disease Progression
10/2014
1Schizophrenia (Dementia Praecox)
04/2012
1Brain Neoplasms (Brain Tumor)
07/2011
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2011
1Urinary Bladder Neoplasms (Bladder Cancer)
11/2009
1Colorectal Neoplasms (Colorectal Cancer)
08/2009
1Acquired Immunodeficiency Syndrome (AIDS)
01/2007
1Carcinoma (Carcinomatosis)
04/2005
1Ovarian Neoplasms (Ovarian Cancer)
11/2003
1Noninfiltrating Intraductal Carcinoma (DCIS)
11/2002

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
01/2018 - 11/2002
8Biomarkers (Surrogate Marker)IBA
10/2021 - 04/2003
7Pharmaceutical PreparationsIBA
10/2021 - 01/2007
4ErbB Receptors (EGF Receptor)IBA
06/2013 - 11/2009
3Hormones (Hormone)IBA
12/2021 - 03/2011
3Paclitaxel (Taxol)FDA LinkGeneric
12/2021 - 10/2021
3Phosphotransferases (Kinase)IBA
06/2013 - 08/2009
3Lapatinib (GW572016)FDA Link
01/2013 - 11/2009
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2021 - 10/2021
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2021 - 10/2021
2Metformin (Glucophage)FDA LinkGeneric
10/2021 - 10/2017
2Tyrosine Kinase InhibitorsIBA
01/2020 - 01/2013
2Insulin (Novolin)FDA Link
01/2020 - 06/2013
2neratinibIBA
01/2018 - 01/2013
2Heme (Haem)IBA
10/2017 - 10/2017
2CytochromesIBA
10/2017 - 10/2017
2BiguanidesIBA
10/2017 - 10/2017
2PhosphoproteinsIBA
11/2009 - 04/2008
1durvalumabIBA
12/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2021
1Immune Checkpoint InhibitorsIBA
12/2021
1olaparibIBA
12/2021
1Trastuzumab (Herceptin)FDA Link
11/2021
1Ado-Trastuzumab EmtansineIBA
11/2021
1pertuzumabIBA
11/2021
1Hemoglobins (Hemoglobin)IBA
10/2021
1ganitumabIBA
10/2021
1Biological ProductsIBA
10/2021
1BMS 754807IBA
01/2020
1Dihydrotachysterol (AT 10)IBA
01/2020
13- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA
01/2020
1AcidsIBA
10/2017
1EicosanoidsIBA
10/2017
1Cytochrome P-450 CYP3AIBA
10/2017
1Mixed Function Oxygenases (Monooxygenases)IBA
10/2017
1Arachidonic Acid (Vitamin F)IBA
10/2017
1ibrutinibIBA
06/2017
1Drug CombinationsIBA
06/2017
1venetoclaxIBA
06/2017
1Matrix Metalloproteinases (MMPs)IBA
10/2014
1IntegrinsIBA
06/2013
1human ERBB2 proteinIBA
01/2013
1histidine-rich proteinsIBA
01/2013
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2013
1TamoxifenFDA LinkGeneric
11/2012
1Estrogen Receptor Modulators (Antiestrogen)IBA
11/2012
1AntibodiesIBA
11/2012
1Messenger RNA (mRNA)IBA
11/2012
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
09/2011
1mirdametinibIBA
09/2011
1GW2974IBA
08/2011
1Tyrosine (L-Tyrosine)FDA Link
08/2011
1VimentinIBA
03/2011
1Mitogen-Activated Protein KinasesIBA
08/2009
1Protein Isoforms (Isoforms)IBA
08/2009
1AndrogensIBA
06/2009
1CaspasesIBA
06/2009
1Mitochondrial Proteins (Mitochondrial Protein)IBA
06/2009
1Phospho-Specific AntibodiesIBA
11/2003
1Mitogen-Activated Protein Kinase 3IBA
11/2003
1IonsIBA
11/2002
1Nucleic AcidsIBA
11/2002
1Fatty Acids (Saturated Fatty Acids)IBA
11/2002
1GelsIBA
11/2002

Therapy/Procedure

12Therapeutics
11/2021 - 01/2007
8Lasers (Laser)
12/2012 - 11/2002
3Neoadjuvant Therapy
12/2021 - 01/2018
1Castration
09/2011
1Drug Therapy (Chemotherapy)
11/2009
1Colectomy
08/2009